| Year |
Citation |
Score |
| 2020 |
Caswell-Jin JL, McNamara KL, Dering J, Chen H, Dichmann R, Perez A, Patel R, Kotler E, Zoeller JJ, Brugge JS, Press MF, Slamon DJ, Curtis C, Hurvitz SA. Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-07-01 |
0.324 |
|
| 2020 |
Zoeller JJ, Vagodny A, Daniels VW, Taneja K, Tan BY, DeRose YS, Fujita M, Welm AL, Letai A, Leverson JD, Blot V, Bronson RT, Dillon DA, Brugge JS. Abstract P3-11-06: Pre-clinical assessment of combined ABT-263/Navitoclax and ABT-414 or ABBV-321 treatment for EGFR-expressing TNBC Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-11-06 |
0.315 |
|
| 2019 |
Zoeller JJ, Vagodny A, Taneja K, Tan BY, O'Brien N, Slamon DJ, Sampath D, Leverson JD, Bronson RT, Dillon DA, Brugge JS. Neutralization of BCL-2/XL enhances the cytotoxicity of T-DM1 in vivo. Molecular Cancer Therapeutics. PMID 30962322 DOI: 10.1158/1535-7163.Mct-18-0743 |
0.314 |
|
| 2019 |
Zoeller JJ, Hurvitz SA, Press MF, Selfors LM, Dering J, Slamon DJ, Brugge JS. Abstract 2978: Clinical evaluation of lapatinib induced BCL-2 adaptive responses Cancer Research. 79: 2978-2978. DOI: 10.1158/1538-7445.Sabcs18-2978 |
0.31 |
|
| 2018 |
Rosenbluth JM, Schackmann R, Li C, Sachs N, Dillon D, Richardson A, Brock J, Garber J, Gray GK, Zoeller J, Boedicker M, Kuiken HJ, Clevers H, Brugge J. Abstract 989: Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages and can form chimeric mammary glands in vivo Cancer Research. 78: 989-989. DOI: 10.1158/1538-7445.Am2018-989 |
0.306 |
|
| 2014 |
Neill T, Zoeller J. Matrix biology highlights. Matrix Biology. 48: 1-2. PMID 26603526 DOI: 10.1016/J.Matbio.2015.11.002 |
0.316 |
|
| 2012 |
Zoeller JJ, Bronson RT, Gilmer TM, Selfors LM, Lu Y, Mills GB, Brugge JS. Abstract P4-08-05: Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo. Cancer Research. 72: 4834-4834. DOI: 10.1158/0008-5472.Sabcs12-P4-08-05 |
0.379 |
|
| 2012 |
Schnaar R, Paulson JC, Macauley MS, Nycholat C, Pfrengle F, Rademacher C, Mahan A, Dionne K, Suscovich T, Alter G, Katoh T, Kiwamoto T, Brummet M, Bochner B, Tiemeyer M, ... ... Zoeller J, et al. Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology Glycobiology. 22: 1518-1650. DOI: 10.1093/Glycob/Cws127 |
0.449 |
|
| 2011 |
Brugge J, Muranen T, Zoeller J, Worster D, Iwanicki M, Selfors L, Mills G. DL1-1: Adaptive Resistance to Targeted Therapies. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Dl1-1 |
0.303 |
|
| 2009 |
San Antonio JD, Zoeller JJ, Habursky K, Turner K, Pimtong W, Burrows M, Choi S, Basra S, Bennett JS, DeGrado WF, Iozzo RV. A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis. The American Journal of Pathology. 175: 1338-47. PMID 19700757 DOI: 10.2353/Ajpath.2009.090234 |
0.556 |
|
| 2009 |
Iozzo RV, Zoeller JJ, Nyström A. Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Molecules and Cells. 27: 503-13. PMID 19466598 DOI: 10.1007/S10059-009-0069-0 |
0.528 |
|
| 2009 |
Zoeller JJ, Whitelock JM, Iozzo RV. Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. Matrix Biology : Journal of the International Society For Matrix Biology. 28: 284-91. PMID 19422911 DOI: 10.1016/J.Matbio.2009.04.010 |
0.555 |
|
| 2009 |
Zoeller JJ, Pimtong W, Corby H, Goldoni S, Iozzo AE, Owens RT, Ho SY, Iozzo RV. A central role for decorin during vertebrate convergent extension. The Journal of Biological Chemistry. 284: 11728-37. PMID 19211552 DOI: 10.1074/Jbc.M808991200 |
0.487 |
|
| 2008 |
Zoeller JJ, McQuillan A, Whitelock J, Ho SY, Iozzo RV. A central function for perlecan in skeletal muscle and cardiovascular development. The Journal of Cell Biology. 181: 381-94. PMID 18426981 DOI: 10.1083/Jcb.200708022 |
0.501 |
|
| 2008 |
Zoeller JJ, Iozzo RV. Proteomic profiling of endorepellin angiostatic activity on human endothelial cells. Proteome Science. 6: 7. PMID 18269764 DOI: 10.1186/1477-5956-6-7 |
0.533 |
|
| 2006 |
Bix G, Castello R, Burrows M, Zoeller JJ, Weech M, Iozzo RA, Cardi C, Thakur ML, Barker CA, Camphausen K, Iozzo RV. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. Journal of the National Cancer Institute. 98: 1634-46. PMID 17105986 DOI: 10.1093/Jnci/Djj441 |
0.513 |
|
| 2006 |
BIX G, BURROWS M, CASTELLO R, ZOELLER J, IOZZO R, CARDI C, THAKUR M, IOZZO R. Actin' Up: Endorepellin and endothelial morphogenesis Matrix Biology. 25: S58-S58. DOI: 10.1016/J.Matbio.2006.08.160 |
0.493 |
|
| Show low-probability matches. |